Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Journal of the European Academy of Dermatology and Venereology : JEADV|August 23, 2023
Risk of serious infection and infection mortality in patients with psoriasis: A nationwide cohort study using the Taiwan National Health Insurance claims databaseTeng-Chou Chen, Ting-Chun Wang, Zenas Z N Yiu, et al.
The Journal of Investigative Dermatology|October 22, 2017
Risk of Serious Infection in Patients with Psoriasis Receiving Biologic Therapies: A Prospective Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR)Zenas Z N Yiu, Catherine H Smith, Darren M Ashcroft, et al.
Clinical and Experimental Dermatology|May 22, 2025
Evaluating changes in baseline characteristics and drug-utilization pattern in patients with moderate-to-severe psoriasis: findings from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR) cohortOras A Alabas, Ian Evans, Kathleen Mcelhone, et al.
The British Journal of Dermatology|March 16, 2026
Using biologic therapies as first-line systemic treatment for psoriasis: A cohort study following the target trial emulation framework from the British Association of Dermatologists Biologics and Immunomodulators Register (BADBIR)Duc Binh Phan, Philip Laws, Catherine H Smith, et al.
The Journal of Investigative Dermatology|March 27, 2021
Meeting Report: Psoriasis Stratification to Optimize Relevant Therapy ShowcaseZenas Z N Yiu, Jonathan N W N Barker, Michael R Barnes, et al.
Dermatology and Therapy|October 31, 2025
Serious Infection Risk with Systemic Treatments for Psoriasis: A Systematic Review and Network Meta-analysis Combining Randomised and Non-randomised EvidenceHeber Rew Bright Bright, Duc Binh Phan, Amna Zahid, et al.
JAMA Dermatology|December 6, 2023
Risk of Paradoxical Eczema in Patients Receiving Biologics for PsoriasisAli Al-Janabi, Oras A Alabas, Zenas Z N Yiu, et al.
JAMA Dermatology|March 29, 2018
Comparison of Drug Discontinuation, Effectiveness, and Safety Between Clinical Trial Eligible and Ineligible Patients in BADBIRKayleigh J Mason, Jonathan N W N Barker, Catherine H Smith, et al.
The Journal of Allergy and Clinical Immunology. in Practice|July 14, 2023
Systematic Review and Critical Appraisal of Urticaria Clinical Practice Guidelines: A Global Guidelines in Dermatology Mapping Project (GUIDEMAP)Hsi Yen, Hsuan Yen, Chun-Hsien Huang, et al.
The British Journal of Dermatology|February 13, 2022
Systematic review and critical appraisal of psoriasis clinical practice guidelines: a Global Guidelines in Dermatology Mapping Project (GUIDEMAP)Hsi Yen, Chun-Hsien Huang, I-Hsin Huang, et al.
Pageof 6